Baillie Gifford & Co’s Asensus Surgical, Inc. ASXC Stock Holding History

Baillie Gifford & Co’s Portfolio ASXC Stock Details ASXC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-5,338	Closed	-$3.5K	–	444
2023 Q1	$3.5K	Hold	5,338	–	–	﹤0.01%	431
2022 Q4	$1.85K	Hold	5,338	–	–	﹤0.01%	471
2022 Q3	$2K	Hold	5,338	–	–	﹤0.01%	473
2022 Q2	$2K	Hold	5,338	–	–	﹤0.01%	479
2022 Q1	$3K	Hold	5,338	–	–	﹤0.01%	489
2021 Q4	$6K	Hold	5,338	–	–	﹤0.01%	477
2021 Q3	$10K	Hold	5,338	–	–	﹤0.01%	450
2021 Q2	$17K	Buy	+5,338	New	+$13.3K	﹤0.01%	372

Other funds holding ASXC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

MCM

Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

AlphaCentric Advisors San Juan, Puerto Rico $118M AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Baillie Gifford & Co's ASXC Position: Q2 2023 in Review

Baillie Gifford & Co sold out of Asensus Surgical, Inc. (ASXC) in Q2 2023, closing a stake of 5,338 shares — an estimated $3.5K sold.

Baillie Gifford & Co first reported a position in ASXC in Q2 2021 and held it in 8 quarters. The position peaked at $17K in Q2 2021. 80 funds tracked by Wall St. Rank hold ASXC as of Q2 2023.

Baillie Gifford & Co reported no remaining Asensus Surgical, Inc. position as of Q2 2023 after selling out during the quarter.
Baillie Gifford & Co sold 5,338 Asensus Surgical, Inc. shares in Q2 2023, an estimated $3.5K.
Baillie Gifford & Co first reported a position in Asensus Surgical, Inc. in Q2 2021 and held it in 8 quarters.
Baillie Gifford & Co's Asensus Surgical, Inc. position peaked at $17K in Q2 2021.
80 funds tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q2 2023.

Based on Baillie Gifford & Co's 13F filing for Q2 2023, filed 28 Jul 2023.